Barbara Ann Karmanos Cancer Institute (Wayne State University) — Detroit, Michigan

Barbara Ann Karmanos Cancer Institute (Wayne State University) is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Institute (Wayne State University) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia.

Sponsors: Imugene Limited.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Institute (Wayne State University)?

Barbara Ann Karmanos Cancer Institute (Wayne State University) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Institute (Wayne State University) conducted?

Barbara Ann Karmanos Cancer Institute (Wayne State University) has 1 clinical trials on record, with 1 currently active. Their work covers Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia.

Is Barbara Ann Karmanos Cancer Institute (Wayne State University) accredited by Crixeo Health?

Barbara Ann Karmanos Cancer Institute (Wayne State University) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Institute (Wayne State University)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.